Entera Bio Ltd.
ENTX · NASDAQ · USD
$2.50
−0.01 −0.40%todayNot financial advice.
- Open
- 2.48
- Day range
- 2.45 - 2.52
- 52-week range
- 0.9100 - 4.20
- Volume
- 421.03K
- Market cap
- 434.59M
- P/E ratio
- —
- EPS
- -0.35
- Dividend yield
- 0.00%
- Beta
- -1.09
Performance
W
−13.49%
1M
−15.25%
3M
+47.93%
6M
+116.68%
YTD
+27.55%
Y
+32.98%
5Y
−43.95%
All
−65.75%
In the news
Oct 7
Entera Bio Appoints Former Gilead Executive Laura Hamill to Board Ahead of Phase 3 Trial
Entera Bio Ltd. appointed former Gilead executive Laura Hamill to its board of directors as it prepares to launch a Phase 3 clinical trial for EB613.
Company news
Embed on your site
Embed docsAdd a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.
<iframe src="https://stocks.freetheai.org/embed/NASDAQ-ENTX" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="Entera Bio Ltd. (ENTX) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/NASDAQ-ENTX">ENTX stock price</a> by FreeTheAI Stocks</p>